Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

<p>The Polθ inhibitor ART558 radiosensitizes tumor cells. <b>A</b> and <b>B,</b> Clonogenic survival of HCT116, H460, and T24 cells treated with ART558 and/or IR. <b>A,</b> Plating efficiency for unirradiated cells. <b>B,</b> Surviving fractions...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	Gonzalo Rodriguez-Berriguete (15056057) (author)
Другие авторы:	Marco Ranzani (15056060) (author), Remko Prevo (15056063) (author), Rathi Puliyadi (15056066) (author), Nicole Machado (15056069) (author), Hannah R. Bolland (15056072) (author), Val Millar (15056075) (author), Daniel Ebner (15056078) (author), Marie Boursier (15056081) (author), Aurora Cerutti (15056084) (author), Alessandro Cicconi (15056087) (author), Alessandro Galbiati (15056090) (author), Diego Grande (15056093) (author), Vera Grinkevich (15056096) (author), Jayesh B. Majithiya (15056099) (author), Desiree Piscitello (15056102) (author), Eeson Rajendra (15056105) (author), Martin L. Stockley (15056108) (author), Simon J. Boulton (15056111) (author), Ester M. Hammond (15056114) (author), Robert A. Heald (15056117) (author), Graeme C.M. Smith (15056120) (author), Helen M.R. Robinson (15056123) (author), Geoff S. Higgins (15056126) (author)
Опубликовано:	2025
Предметы:	Cancer Molecular and Cellular Biology Therapeutic Research and Development DNA Damage and Repair DNA repair Radiation Oncology Molecular targets of radiation response Small Molecule Agents
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
по: Gonzalo Rodriguez-Berriguete (15056057)
Опубликовано: (2025)

Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
по: Gonzalo Rodriguez-Berriguete (15056057)
Опубликовано: (2025)

Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
по: Gonzalo Rodriguez-Berriguete (15056057)
Опубликовано: (2025)

Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
по: Gonzalo Rodriguez-Berriguete (15056057)
Опубликовано: (2025)

Supplementary Table S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
по: Gonzalo Rodriguez-Berriguete (15056057)
Опубликовано: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
по: Sami Belhadj (15052341)
Опубликовано: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
по: Bouchra Tawk (15389486)
Опубликовано: (2025)

Supplementary Table S1 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
по: Mengjie Zhao (14845174)
Опубликовано: (2025)

Supplementary Table S2 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
по: Mengjie Zhao (14845174)
Опубликовано: (2025)

Supplementary Table S4 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
по: Mengjie Zhao (14845174)
Опубликовано: (2025)

Supplementary Table S5 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
по: Mengjie Zhao (14845174)
Опубликовано: (2025)

Supplementary Table S8 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
по: Mengjie Zhao (14845174)
Опубликовано: (2025)

Supplementary Figure 1. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 11 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 12 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 13 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 14 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 15 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 16 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 17 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 18 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 2 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 20 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 21 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 22. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 23. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 24 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 25 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 26 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 27 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 28 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 29 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 3 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 4. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 5 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 6 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 7 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Supplementary Figure 8 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
по: Biagio Ricciuti (14951247)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_r8i82egpbcqrp21ih11hfnsp2q